Yoga as therapeutic intervention in women with breast cancer during chemotherapy

Not Applicable

• Conditions: breast cancer; C50; Malignant neoplasm of breast

• Registration Number: DRKS00010810
• Lead Sponsor: Klinikum rechts der Isar der TU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2014-09-25
• Study Start: 2016-07-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 119

Inclusion Criteria

Women with stage I-III breast cancer undergoing cytotoxic (neo)adjuvant or endocrine adjuvant therapy at the moment of intervention
- signed informed consent

Exclusion Criteria

In case of acute febrile or psychiatric diseases, patients were excluded from the study. Also women who had experiences in practicing yoga were not included.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Inner correspondence (Measurement with a questionnaire at intervention start, in the middle and after the intervention period)

Secondary Outcome Measures

Name	Time	Method
Quality of life (EORTC C-30), life satisfaction (Brief Multidimensional Life Satisfaction Scale), fatigue (Cancer Fatigue Scale) and mindfulness (Freiburger Achtsamkeits-Inventar), spiritual attitudes and coping with illness (Spiritual/Religious Attitudes and Coping with Illness questionnaire); measurement with questionnaire at intervention start, after the intervention period and three months after the end of intervention<br>